CrushSCI.com
84.0Average days
60Median days
1Fastest days
242Longest days
1932025 publications

Paper Review Records

All Paper Review Records

21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

29 days

Treatment outcomes and safety of oral β-blockers and sirolimus in children with kaposiform hemangioendothelioma: a single-center retrospective cohort study

Authors
Yi Tian; Li Wei; Li Li; Lin MaShow moreShow less
Affiliations
1. Department of Dermatology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health; 2. Key Laboratory of Major Diseases in Children, Ministry of EducationShow moreShow less
Source PDF DOI Publisher page
53 days

Balancing safety and efficacy in photodynamic therapy for facial port-wine stains in children aged 2-7 years: a prospective controlled study of light-intensity optimization

Authors
Jiawen Qin; Xiaoxi Lin; Yue Han; Yize Zhang; Jingyan Huang; Cara Kou Yan; Xiaolin Zhang; Gang Ma; Hanru YingShow moreShow less
Affiliations
1. Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine; 2. Department of Laser and Aesthetic Medicine, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of MedicineShow moreShow less
Source PDF DOI Publisher page
48 days

5-Aminolevulinic acid-based photodynamic therapy used as a long-term management approach for refractory lichen sclerosus

Authors
Yitao Qian; Wenjing Zha; Jie Shen; Ke Li; Shimin Zhang; Yiwu Yu; Jianhua Huang; Ting Lyu; Fei Miao; Qianyi Chen; Yijing Wang; Hongwei Wang; Lei ShiShow moreShow less
Affiliations
1. Department of Dermatology, Huadong Hospital, Fudan University; Shanghai Key Laboratory of Clinical Geriatric Medicine; Shanghai Institute of Geriatric MedicineShow moreShow less
Source PDF DOI Publisher page
56 days

Long-term efficacy of lebrikizumab in treating head, neck and face involvement in patients with moderate-to-severe atopic dermatitis

Authors
Raj Chovatiya; Marjolein de Bruin-Weller; Andrew Alexis; Chesahna Kindred; Mona Shahriari; Jill Waibel; Christian Vestergaard; Natalie Nunez Gomez; Khai Jing Ng; Lucia Seminario-Vidal; Zach Dawson; Chao Yang; Yuxin Ding; Julien SeneschalShow moreShow less
Affiliations
1. Rosalind Franklin University of Medicine and Science Chicago Medical School; 2. Center for Medical Dermatology and Immunology Research; 3. Department of Dermatology and Allergology, University Medical Center Utrecht; 4. Weill Cornell Medicine; 5. Howard University; 6. Department of Dermatology, Yale University; 7. Central Connecticut Dermatology; 8. Miami Dermatology and Laser Institute; 9. Department of Dermatology, Aarhus University Hospital; 10. Almirall; 11. Eli Lilly and Company; 12. CHU de Bordeaux, Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, UMR 5164Show moreShow less
Source PDF DOI Publisher page
1 days

Adalimumab durability in hidradenitis suppurativa: persistence is not synonymous with sustained response

Authors
Abdullah Demirbas; Esin DiremsizogluShow moreShow less
Affiliations
1. Faculty of Medicine, Department of Dermatology, Kocaeli UniversityShow moreShow less
Source PDF DOI Publisher page
72 days

Surgical management of dissecting cellulitis of the scalp: a narrative review of techniques, patient selection, and integration with medical therapy

Authors
Junyou Zheng; Wenbo Bu; Xiaofang Li; Fang FangShow moreShow less
Affiliations
1. Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College; 2. Department of Dermatologic Surgery, Shanghai Skin Disease HospitalShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF DERMATOLOGICAL TREATMENT take to review a manuscript?

As of 2026-11-19, CrushSCI has 21 complete review records for JOURNAL OF DERMATOLOGICAL TREATMENT. The fastest paper went from submission to acceptance in 1 days (Adalimumab durability in hidradenitis suppurativa: persistence is not synonymous with sustained response, received 2026-10-08, accepted 2026-10-09); the slowest took 242 days. The average is 84.0 days and the median is 60 days. The fastest record has an unusually short interval; please check the original source.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.